BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28971639)

  • 21. The Ceraflex and Figulla atrial septal occluders: early and intermediate-term safety and efficacy study.
    Leong MC; Karyostyko B; Ramli MNH; Tan JWY; Alwi M
    Cardiol Young; 2022 Oct; 32(10):1621-1627. PubMed ID: 35321770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept.
    Georgiev S; Tanase D; Genz T; Ewert P; Naumann S; Pozza RD; Eicken A
    Cardiol Young; 2018 Jul; 28(7):955-960. PubMed ID: 29779498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of percutaneous and intra-operative device closure of atrial septal defects under transesophageal echocardiographic guidance: one center experience and mid-term follow-up.
    Zhu P; Qiang H; Liu F; Xie P; Zheng S; Sun Y
    J Cardiothorac Surg; 2020 Jan; 15(1):20. PubMed ID: 31937330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
    Pedra CA; Pedra SF; Costa RN; Ribeiro MS; Nascimento W; Campanhã LO; Santana MV; Jatene IB; Assef JE; Fontes VF
    J Interv Cardiol; 2016 Apr; 29(2):208-15. PubMed ID: 26927945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of transcatheter closure in unselected patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon technique.
    Kammache I; Mancini J; Ovaert C; Habib G; Fraisse A
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):665-74. PubMed ID: 21812090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of percutaneous closure of atrial septal defects in adults under transthoracic echocardiography guidance using the Figulla atrial septal defect occluder device.
    Ali M; Salah El-Din H; Bakhoum S; El-Sisi A; Mahmood K; Farouk H; Kandil H
    J Saudi Heart Assoc; 2018 Jan; 30(1):21-27. PubMed ID: 29296061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter Closure of an Atrial Septal Defect.
    Ueda H
    Intern Med; 2022 Jan; 61(1):1-2. PubMed ID: 33583908
    [No Abstract]   [Full Text] [Related]  

  • 29. Initial clinical experience with the GORE
    de Hemptinne Q; Horlick EM; Osten MD; Millán X; Tadros VX; Pighi M; Gonzalez Barlatey F; Alnasser SM; Miró J; Asgar AW; Ibrahim R
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):495-503. PubMed ID: 28128523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New modified balloon-assisted technique to provide appropriate deployment in the closure of large secundum atrial septal defect using amplatzer septal occluder in children.
    Narin N; Baykan A; Argun M; Ozyurt A; Pamukcu O; Bayram A; Uzum K
    J Invasive Cardiol; 2014 Nov; 26(11):597-602. PubMed ID: 25364001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.
    Haas NA; Soetemann DB; Ates I; Baspinar O; Ditkivskyy I; Duke C; Godart F; Lorber A; Oliveira E; Onorato E; Pac F; Promphan W; Riede FT; Roymanee S; Sabiniewicz R; Shebani SO; Sievert H; Tin D; Happel CM
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):571-581. PubMed ID: 27029396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of maximum P-wave duration and dispersion after percutaneous closure of atrial septal defects: comparison of two septal occluders.
    Paç FA; Balli S; Topaloğlu S; Ece I; Oflaz MB
    Anadolu Kardiyol Derg; 2012 May; 12(3):249-54. PubMed ID: 22381925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Multicenter clinical experience.
    Astarcioglu MA; Kalcik M; Sen T; Aykan AC; Gokdeniz T; Gursoy OM; Karakoyun S; Kulahcioglu S; Gunduz S; Kilit C; Oylumlu M; Amasyali B
    Herz; 2015 Apr; 40 Suppl 2():146-50. PubMed ID: 25662695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
    Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preprocedural Transthoracic Echocardiography Can Predict Amplatzer Septal Occluder Device Size for Transcatheter Atrial Septal Defect Closure.
    Sah SP; Bartakian S; El-Said H; Molkara DP; Printz B; Moore JW
    Congenit Heart Dis; 2016 Dec; 11(6):656-662. PubMed ID: 27079542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Device closure of atrial septal defects with the Amplatzer septal occluder: safety and outcome in infants.
    Diab KA; Cao QL; Bacha EA; Hijazi ZM
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):960-6. PubMed ID: 17903514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.
    Grohmann J; Wildberg C; Zartner P; Abu-Tair T; Tarusinov G; Kitzmüller E; Schmoor C; Stiller B; Kampmann C
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):E226-E232. PubMed ID: 27900839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catheter closure of perforated secundum atrial septal defect under intracardiac echocardiographic guidance using a single amplatzer device: feasibility of a new method.
    Zanchetta M; Rigatelli G; Pedon L; Zennaro M; Carrozza A; Onorato E
    J Invasive Cardiol; 2005 May; 17(5):262-5. PubMed ID: 15879606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new device to close secundum atrial septal defects: first clinical use to close multiple defects in a child.
    Halabi A; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 May; 71(6):853-6. PubMed ID: 18412085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR
    J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.